The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle

Duchenne muscular dystrophy (DMD) is one of the most devastating myopathies, where severe inflammation exacerbates disease progression. Previously, we demonstrated that adiponectin (ApN), a hormone with powerful pleiotropic effects, can efficiently improve the dystrophic phenotype. However, its prac...

Descrición completa

Detalles Bibliográficos

Principais autores:	Nicolas Dubuisson, Romain Versele, Maria A. Davis-López de Carrizosa, Camille M. Selvais, Laurence Noel, Chloé Planchon, Peter Y. K. Van den Bergh, Sonia M. Brichard, Michel Abou-Samra
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2023-08-01
Series:	Cells
Assuntos:	duchenne muscular dystrophy adiponectin ALY688 skeletal muscle AMPK inflammation
Acceso en liña:	https://www.mdpi.com/2073-4409/12/16/2101
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!